#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Asthma Factor VIII deficiency Chondrosarcoma Albright's disease Langerhans cell sarcoma Myeloid leukaemia Von Hippel-Lindau disease Polyneuropathy Leber's congenital amaurosis Urea cycle disorder Myelodysplastic syndrome with excess blasts T-cell lymphoma Familial amyotrophic lateral sclerosis Bronchiolitis HER2 gene amplification More trials…

    Learn about Rare Diseases

    Idiopathic inflammatory myopathy Mucous membrane pemphigoid – Diagnostics Epidermolysis bullosa Chronic granulomatous disease – Basic Information Synovial sarcoma recurrent Atypical teratoid/rhabdoid tumour of CNS – Treatment Ornithine transcarbamoylase deficiency – Basic Information Alternating hemiplegia of childhood – Diagnostics Hypereosinophilic syndrome – Diagnostics Cytokine release syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Berotralstat BW-20805 Insulin Icodec ZELENECTIDE PEVEDOTIN IG-TREGS Elamipretide Trihydrochloride A/H1N1 INFLUENZA VACCINE Magnesium Linezolid Dimethyl Fumarate Guanabenz Acetate Azd5863 Obefazimod Coffee Charcoal Vitamin A Bp LINAPRAZAN GLURATE Ipratropium Bromide Rebisufligene Etisparvovec Afimetoran Besilate Dihydrate Clemastine Fumarate More therapies…

    Learn about Your Condition

    Underweight Adrenal insufficiency Neurogenic bladder Diminished ovarian reserve Hepatitis alcoholic Cancer pain Autoimmune uveitis Primary adrenal insufficiency Bone marrow failure Tinnitus Neurotrophic keratopathy Anal cancer stage II Gastrointestinal melanoma Colorectal adenoma Lip and/or oral cavity cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Gout: Comparing Immediate vs. Delayed Use of Febuxostat for Patients with Acute Gout Attacks

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Gout
    Investigated Drugs:
    • Febuxostat
    France

  • Study on Itacitinib for Adults with Diffuse Systemic Sclerosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Itacitinib
    France

  • Study on the Safety and Effectiveness of Naronapride for Adults with Moderate Idiopathic or Diabetic Gastroparesis

    Not recruiting

    2 1
    Investigated Diseases:
    • Diabetic gastroparesis
    • Impaired gastric emptying
    Investigated Drugs:
    • Naronapride Dihydrochloride Trihydrate
    Austria Belgium France Germany Italy Latvia +2

  • Study on Capivasertib and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Capivasertib
    • Docetaxel
    Belgium Czechia France Greece Hungary The Netherlands +2

  • Study of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Pemphigoid
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Dupilumab
    France Germany Poland Spain

  • Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bimekizumab
    Bulgaria France Germany Greece Ireland Italy +3

  • Study on the Safety and Immune Response of Meningococcal B Vaccines in Adults with Asplenia: Bexsero, Trumenba, and a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asplenia
    Investigated Drugs:
    • Neisseria Meningitidis Group B Fhbp Protein Subfamily A
    • Neisseria Meningitidis Group B Fhbp Protein Subfamily B
    • Outer Membrane Vesicles (Omv) From Neisseria Meningitidis Group B Strain Nz98/254 Measured As Amount Of Total Protein Containing The Pora P1.4 Adsorbed On Aluminium Hydroxide
    France

  • Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

    Not recruiting

    4 1
    Investigated Diseases:
    • Idiopathic inflammatory myopathy
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Belgium Bulgaria Cyprus Czechia Denmark +13

  • Study on Adjuvant Treatment for Unilateral Retinoblastoma with Vincristine Sulfate and Drug Combination in Patients After Primary Eye Removal

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Retinoblastoma
    Investigated Drugs:
    • Carboplatin
    • Cyclophosphamide
    • Etoposide
    France

  • Study on Nivolumab and Tisagenlecleucel for Children, Adolescents, and Young Adults with Acute Lymphoblastic Leukemia After Treatment Loss

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Nivolumab
    • Tisagenlecleucel
    France
Previous Page
1 … 31 32 33 34 35 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!